Emgality for Migraine

Help prevent migraine days before they start with Emgality

Emgality reduced the average number of migraine days each month in clinical trials

For those who had 4-14 migraine days per month,
Emgality cut the number of monthly migraine days by:

In a study, the number of people with ≥15 headache days per month who achieved 75% reduction in monthly migraine days did not differ from people taking placebo.

For those who had 15 or more headache days per month,
Emgality cut the number of monthly migraine days by:

Select Important Safety Information
Emgality may cause allergic reactions, such as itching, rash, hives, and trouble breathing. Allergic reactions can happen days after using Emgality. Call your healthcare provider or get emergency medical help right away if you have any of the following symptoms, which may be part of an allergic reaction:

  • swelling of your face, mouth, tongue, or throat

  • trouble breathing

Share with a friend:

Share on FacebookCopy link

Ask your doctor if once-monthly Emgality is right for you

Emgality was specifically developed for migraine

Historically, many migraine preventive medicines were designed for other conditions

Emgality was specifically developed to bind to CGRP, a substance in the brain that may play a key role in migraine.

CGRP = calcitonin gene-related peptide.

Looking to talk to a doctor about migraine?

Find a doctor near you:

Search the American Migraine Foundation (AMF) or the National Headache Foundation (NHF).

INDICATIONS AND IMPORTANT SAFETY INFORMATION

INDICATION

Emgality is indicated for the preventive treatment of migraine in adults.

IMPORTANT SAFETY INFORMATION ABOUT EMGALITY (GALCANEZUMAB-GNLM)

Do not use Emgality if you are allergic to galcanezumab-gnlm or any of the ingredients in Emgality.


Emgality may cause serious side effects, including: allergic reactions, such as itching, rash, hives, and trouble breathing. Allergic reactions can happen days after using Emgality. Call your healthcare provider or get emergency medical help right away if you have any of the following symptoms, which may be part of an allergic reaction:

  • swelling of your face, mouth, tongue, or throat

  • trouble breathing

Before you use Emgality, tell your healthcare provider if you are:

  • pregnant or plan to become pregnant. It is not known if Emgality will harm your unborn baby

  • breastfeeding or plan to breastfeed. It is not known if Emgality passes into breast milk

  • taking any prescription or over-the-counter medicines, vitamins, or herbal supplements

The most common side effects of Emgality include: Injection site reactions

Tell your healthcare provider if you have any side effect that bothers you or does not go away. These are not all the possible side effects of Emgality. For more information, ask your healthcare provider or pharmacist.

You can report side effects to the Food and Drug Administration (FDA) at www.fda.gov/medwatch or by calling 1-800-FDA-1088.

Emgality is available by prescription only.

Please see Prescribing Information, including Patient Information, for Emgality. See Instructions for Use included with the pen and prefilled syringe.

GZ CON ISI 27SEP2018

Emgality™ is a trademark owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates.

This site is intended for US residents ages 18 and older.

Questions? Call the Emgality Answers Center:
1-833-EMGALITY (1-833-364-2548)

PP-GZ-US-0365 10/2018 ©Lilly USA, LLC 2018. All rights reserved.

https://www.emgality.com/what-is-emgality